The BIO CEO & Investor Conference
Save the Date! February 11-12, 2013 in NYC
The BIO CEO & Investor Conference is the largest investor conference focused on established and emerging publicly traded biotech companies. Because our mission is to support industry-wide success, we present a broad and unbiased view of investment opportunities.
BIO One-on-One Partnering provides an opportunity to arrange meetings between investors; companies; and industry BD, licensing and therapeutic franchise heads.
2012 Conference News and Updates
• Follow the BIO team on Twitter for the most up-to-date information onsite! Use the hashtag #BIOCEO2012 to stay connected: @bio1x1 and @InsideBioIA
• The BIO CEO 2012 Company Profiles are up! View Profiles
• Optimer Has Big Plans for Antibiotic: Article -- Hear more on February 14, 9:00am
• Program Grid Now Available: Download
• Pfizer President of WW R&D to speak in BIO CEO Fireside Chat: Program
• January's Presenting Company Breakdown: Download
• Company Snapshot - NuPathe Inc: Blog
• Over 135 Companies Set to Present: List
• GSK Head of R&D to speak in BIO CEO Fireside Chat: Program
2012 Presenting Company Highlights
• FDA Approves Roche, Curis Skin-Cancer Drug: Release
• EpiCept Announces FDA Permission: Release
• Trius Therapeutics Meets Study Goals: Article
• Rigel Announces Initiation: Release
• NovaBay Announces Agreement: Release
• Synta Rises as Analyst Weighs Drug: Article
• BioLineRx Announces Development: Release
• StemCells Announces Closing of Offering: Release
• CytRx Announces Initiation: Release
• Chelsea Reports Phase 2 Results: Release
Blog Posts from BIO’s BiotechNow
• Big 2012 start for the BTK: Blog
• Reviewing the drug class of 2011: Blog
• VC Recap for 2011 - Up or down? Blog
• ImmunoGen Company Snapshot: Blog
• NBI 2011 Performance: Blog
• IPO Update, January 2012: Blog
• VRUS / GILD Perspective: Blog
• Public Exits and virtual Biotech: Blog
• Perspective on Biotech Market Valuation: Blog
